|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.020 USD | -8.18% |
|
-9.42% | -85.76% |
| 06-02 | NextCure, Inc. - Special Call | |
| 06-01 | NextCure, Inc. Presents Positive SIM0505 Phase 1 Dose Escalation Data In Patients With Gynecologic Cancers At ASCO | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- NXTC Stock
- Consensus NextCure, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
